Home » Topics » Regulatory » Patents

Patents
RSS

Aska Pharmaceuticals describes novel PPAR activators

Aug. 21, 2009

Novel c-Met inhibitors designed at sanofi-aventis

Aug. 21, 2009

Biovitrum AB reports the invention of 11beta-HSD1 inhibitors for glaucoma

Aug. 21, 2009

Glenmark discloses novel VR1 antagonists for the treatment of pain

Aug. 21, 2009

GABA-A alpha5 receptor ligands for cognitive disorders presented by Roche

Aug. 21, 2009

Oligomer-guanidine conjugates active against pain claimed by Nektar Therapeutics

Aug. 21, 2009

Genentech and Array BioPharma report novel Akt-1 protein kinase inhibitors

Aug. 21, 2009

Abbott discloses new calpain inhibitors for neurological and other disorders

Aug. 20, 2009

LXR ligands for a variety of potential applications described by Wyeth

Aug. 20, 2009

Cathepsin K inhibitors identified at Amura for treating bone disorders

Aug. 20, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...